CardioComm Solutions, Inc

CardioComm Press Releases
 
  Previous Page previous page
About CardioComm
 

Letter from the CEO, January 24, 2014

Dear Shareholders,

I am providing this update regarding the CardioComm Solutions' Private Placement Opportunity. Specifically, interested investors should be aware that the private placement opportunity may have to be re-priced based on market value of our shares, especially a market shares value change occurs following a press releases we make.

Share prices under our open $1M private placement have been based on a discount to the market. We initially priced shares at $0.12 and then re-priced at $0.0675 based on a change (lowering) of the market share price for our stock.
(see http://www.cardiocommsolutions.com/news/2014/CCSnews_010914.html)

We are now at the end of the second week following announcing a 6.75 cent per share investment opportunity and we have close a first tranche of that investment opportunity in the $100,000 range.

Our stock now has a market price of 10.50 cents per share. If we were to close a tranche of equity financing now, the best discount at 25% would be an $0.08 per share offer. The original option of $0.0675 was based on a market share price of $0.09 per share.

We are taking this opportunity to provide advanced notice to anyone who was interested in the 6.75 cent per share offering, that we may need to re-price the offer at $0.08 based on a closing market price for our $0.105 per share (today's market price).

As we cannot determine what the market may do with respect to stock price, we wish to advise our shareholders that any discounted share price offer may not be possible to maintain for an extended period of time especially following any press release that CardioComm Solutions may make.

Should you have an interest to be involved or would like more information, please contact me by email at egrima@cardiocommsolutions.com or directly at 416-977-9425 ext. 227 to discuss in further detail.

Kind regards,

Etienne Grima CEO of CardioComm Solutions, Inc.

The Medical Post Article

Forward-looking statements
This release may contain certain forward-looking statements with respect to the financial condition, results of operations and business of CardioComm Solutions and certain of the plans and objectives of CardioComm Solutions with respect to these items. By their nature, forward-looking statements involve risk and uncertainty because they relate to events and depend on circumstances that will occur in the future and there are many factors that could cause actual results and developments to differ materially from those expressed or implied by these forward-looking statements.

 







Investor Information


January 21, 2014

Today The Medical Post published a short article reviewing the use of pulse check technologies versus ECGs for the detection of Atrial Fibrillation (AF) in two separate studies..


January 16, 2014

I am providing this update regarding CardioComm Solutions' Private Placement.


December 19 2013

I have This is a special CEO update to provide news related to our HeartCheckTM sales and marketing efforts. e.


December 18 2013

I have summarized our activities and highlighted the opportunities that are working to realize.


July 9 2013

I acknowledge that shareholders and interested parties wish to have news about HeartCheck? PEN sales


December 11, 2012
November was a quiet month with respect to press releases from CardioComm Solutions (CCS); however, we?ve been very busy behind the scenes developing new channels for the promotion of our devices and software.


November 23, 2012
CardioComm Solutions, Inc. is pleased to confirm their participation in a BTV news release


November 1, 2012
The past few weeks have been very busy for CardioComm Solutions.


September 25, 2012
2012 North American Award for Enabling Technology for Cardiac Monitoring Technology


August 30, 2012
Heart and Stroke Foundation's Atrial Fibrillation screening booth set up at the Canadian National Exhibition


August 28, 2012
Invitations for HeartCheck?
PEN Device & Smart Monitoring Product Evaluation Starts this Week.



July 31, 2012
We are pleased to provide a preview of the new HeartCheck? PEN product brochure that is now available on our website



June 27 2012
About WAISCO Inc from Medical
Coaches Incorporated




June 20 2012
"It?s been a busy two months for CardioComm Solutions, Inc."




April 30 2012
"CardioComm receives excellent initial response from Hospimedica International Advertising Campaign"



April 27 2012

CardioComm attends the World Congress of Cardiology Scientific Sessions in Dubai



May 8 2012

CardioComm Solutions Schedules Annual General Meeting (AGM) for June 27th, 2012



June 3 2013
Letter from the CEO


 


Investor Information


Etienne Grima
- MSc CHE
Chief Executive Officer

Anatoly Langer
MD, M.Sc, FRCPC, FACC
Chairman of the Board

William E. Smith
Board Member

Yury Levin

Board Member

David Newman
Board Member

Simi Grosman - MBA

Consultant & Board Member

Investor Information


Etienne Grima - MSc CHE
Chief Executive Officer

Wendy Hsieh
Chief Financial Officer

Wade Barnes
Chief Technology Officer

View more

 

Arrhythmia EKG Management | 12 Lead ECG Management | ECG Software | EKG Management | Web Based ECG | EKG Software